Post-operative Pain Management Market- Overview:
Patient’s comfort is of the utmost priority in the healthcare sector, and post-operative pain management has a significant role to play in it. Pain is an unavoidable result in a post-operative scenario due to tissue injury and muscle spasm which can be treated with proper medication. The global post-operative pain management market is thriving on this. With an intent to mobilize the patient at the earliest and resume their ability to breathe and eat, physicians introduce these post-operative drugs. The demand for drugs and devices to treat such cases are on the rise as healthcare is now permeating to a wider patient pool. This has increased the number of surgeries where the requirement for such devices is obvious.
Furthermore, age becomes a complication as the reception of drugs in such cases differ from any normal patients which opens up scope for new drugs and researches. The global post-operative pain management market is set to grow with 5.4% CAGR during the forecast period (2017-2023), reveals Market Research Future (MRFR). The report has its finger on segmental analysis and factors that can be of great importance for the market in the coming years.
On the flipside, these drugs often become a habit and overdose of it can cause fatal damage. This can be a daunting threat to the post-operative pain management market. As per the Centre for Disease Control and Prevention, the last decade has already witnessed a steep rise in the number of deaths caused by such overdoses.
Post-operative Pain Management Market Segmentation:
The global post-operative pain management market can be segmented by pain type, product, application, and target area.
Based on the pain type, the post-operative pain management market can be segmented into acute pain, moderate pain, and severe pain.
On the basis of product, the post-operative pain management market includes non-steroidal anti-inflammatory drugs (NSAIDs), antiepileptic drugs, COX-2 inhibitors, opioids, and other analgesics.
Application-wise, the post-operative pain management market comprises cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine, and others.
Based on target area, the post-operative pain management market comprises back, legs, hand, arms and other.
Post-operative Pain Management Market Regional Analysis:
Geographically, the global post-operative pain management market includes the Americas, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA).
The Americas is having a great run in the global post-operative pain management market due to the large patient pool availing treatment and surgical procedures. Superlative healthcare infrastructure is also impacting the market significantly in this region.
Europe accounts for the second largest revenue share owing to the increasing research and development (R&D) activities for the introduction of new drugs with fewer side-effects. Both private and public sectors are investing significant sums for R & D which is pushing the market forward.
The APAC is set for the fastest growth during the forecast period. The huge patient pool is expected to provide traction to the market. The post-operative pain management market in the MEA is projecting steady growth. However, lack of awareness and poor primary health care services in the underdeveloped areas of this region are posing great threats to the market.
Competitive Analysis:
The prominent players profiled in the global post-operative pain management market are Johnson & Johnson (the U.S.), Purdue Pharma (the U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer (the U.S.), Eli Lilly (the U.S.), Endo Pharmaceuticals Plc. (the U.S.), Forest Laboratories Inc. (the U.S.), GlaxoSmithKline Plc. (the U.K.), Baxter International Inc. (the U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Valeant Pharmaceuticals International Inc. (Canada), and others.
In August 2018, a panel of expert researchers from the John Hopkins University, a private American university, have declared operation-specific prescribing guidelines for 20 common surgical procedures.
In October 2018, the American Society of Anesthesiologists published a report that talked about a new form of anesthesia used during the treatment of breast cancer. The new procedure is a regional anesthesia technique that includes treatment by injecting long-acting anesthetics, directed by ultrasound, to numb the front part of the chest wall.
